Nesiritide superior to nitroglycerin in decompensated CHF

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1332, 2002-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nesiritide tops nitroglycerin in acute decompensated CHF

By  

Inpharma, Vol. 1, Iss. 1270, 2001-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

An update on nesiritide for treatment of decompensated heart failure

By Hobbs R.E.   Mills R.M.   Young J.B.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 935-942

Informa Healthcare

Access to resources Recommend Favorite

Dobutamine, nesiritide: different effects on HR variability in CHF

By  

Inpharma, Vol. 1, Iss. 1472, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Nesiritide in the Treatment of Acute Decompensated Heart Failure

By Yancy Clyde W.  

Drug Safety, Vol. 30, Iss. 9, 2007-01 ,pp. : 765-781

Adis International

Access to resources Recommend Favorite

Nesiritide: A Review of its Use in Acute Decompensated Heart Failure

By Keating G.M.   Goa K.L.  

Drugs, Vol. 63, Iss. 1, 2003-01 ,pp. : 47-70

Adis International

Access to resources Recommend Favorite